NCT07214337

Digital Inhaler Use in Obstructive Lung Disease Care

Feasibility, Adoption and Efficacy of Digital Inhaler in the Management of Obstructive Lung Disease

• Status: Not Yet Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: Cedars-Sinai Medical Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is a pilot study to evaluate the role digital inhaler technology on patients with obstructive lung disease in preventing admissions and exacerbation, as well as improving symptom control. The primary objective is to evaluate feasibility of study protocol, patient recruitment, and patient retention with goal recruitment of 20 participants, 60% recruitment success, and 60% retention rate for 6 months duration. The secondary objectives are the evaluation of patient admission rate, exacerbation rates, and symptoms control with use of digital inhaler technology The subject population will be patients with physician diagnosed obstructive lung disease.

Conditions

• Chronic Obstructive Airways Disease Exacerbated
• Chronic Obstructive Airway Disease

Interventions

Type	Name	Description
DEVICE	Digital Inhaler Attachment	This intervention is the attachment of a digital device to provide patient with coaching for optimal inhaler use and technique, as well as monitoring of patient use of inhaler to patient and health care team. Patient will continue to use inhalers prescribed as per usual care for management of COPD.

Timeline

• Start date: 2025-11-01
• Primary completion: 2027-01-01
• Completion: 2027-06-01
• First posted: 2025-10-09
• Last updated: 2025-10-09

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study